@inproceedings{su-etal-2022-roberta,
title = "{R}o{BERT}a-based Traditional {C}hinese Medicine Named Entity Recognition Model",
author = "Su, Ming-Hsiang and
Lee, Chin-Wei and
Hsu, Chi-Lun and
Su, Ruei-Cyuan",
booktitle = "Proceedings of the 34th Conference on Computational Linguistics and Speech Processing (ROCLING 2022)",
month = nov,
year = "2022",
address = "Taipei, Taiwan",
publisher = "The Association for Computational Linguistics and Chinese Language Processing (ACLCLP)",
url = "https://aclanthology.org/2022.rocling-1.8",
pages = "61--66",
abstract = "In this study, a named entity recognition was constructed and applied to the identification of Chinese medicine names and disease names. The results can be further used in a human-machine dialogue system to provide people with correct Chinese medicine medication reminders. First, this study uses web crawlers to sort out web resources into a Chinese medicine named entity corpus, collecting 1097 articles, 1412 disease names and 38714 Chinese medicine names. Then, we annotated each article using TCM name and BIO tagging method. Finally, this study trains and evaluates BERT, ALBERT, RoBERTa, GPT2 with BiLSTM and CRF. The experimental results show that RoBERTa{'}s NER system combining BiLSTM and CRF achieves the best system performance, with a precision rate of 0.96, a recall rate of 0.96, and an F1-score of 0.96.",
language = "Chinese",
}
<?xml version="1.0" encoding="UTF-8"?>
<modsCollection xmlns="http://www.loc.gov/mods/v3">
<mods ID="su-etal-2022-roberta">
<titleInfo>
<title>RoBERTa-based Traditional Chinese Medicine Named Entity Recognition Model</title>
</titleInfo>
<name type="personal">
<namePart type="given">Ming-Hsiang</namePart>
<namePart type="family">Su</namePart>
<role>
<roleTerm authority="marcrelator" type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Chin-Wei</namePart>
<namePart type="family">Lee</namePart>
<role>
<roleTerm authority="marcrelator" type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Chi-Lun</namePart>
<namePart type="family">Hsu</namePart>
<role>
<roleTerm authority="marcrelator" type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Ruei-Cyuan</namePart>
<namePart type="family">Su</namePart>
<role>
<roleTerm authority="marcrelator" type="text">author</roleTerm>
</role>
</name>
<originInfo>
<dateIssued>2022-11</dateIssued>
</originInfo>
<typeOfResource>text</typeOfResource>
<language>
<languageTerm type="text">Chinese</languageTerm>
<languageTerm type="code" authority="iso639-2b">chi</languageTerm>
</language>
<relatedItem type="host">
<titleInfo>
<title>Proceedings of the 34th Conference on Computational Linguistics and Speech Processing (ROCLING 2022)</title>
</titleInfo>
<originInfo>
<publisher>The Association for Computational Linguistics and Chinese Language Processing (ACLCLP)</publisher>
<place>
<placeTerm type="text">Taipei, Taiwan</placeTerm>
</place>
</originInfo>
<genre authority="marcgt">conference publication</genre>
</relatedItem>
<abstract>In this study, a named entity recognition was constructed and applied to the identification of Chinese medicine names and disease names. The results can be further used in a human-machine dialogue system to provide people with correct Chinese medicine medication reminders. First, this study uses web crawlers to sort out web resources into a Chinese medicine named entity corpus, collecting 1097 articles, 1412 disease names and 38714 Chinese medicine names. Then, we annotated each article using TCM name and BIO tagging method. Finally, this study trains and evaluates BERT, ALBERT, RoBERTa, GPT2 with BiLSTM and CRF. The experimental results show that RoBERTa’s NER system combining BiLSTM and CRF achieves the best system performance, with a precision rate of 0.96, a recall rate of 0.96, and an F1-score of 0.96.</abstract>
<identifier type="citekey">su-etal-2022-roberta</identifier>
<location>
<url>https://aclanthology.org/2022.rocling-1.8</url>
</location>
<part>
<date>2022-11</date>
<extent unit="page">
<start>61</start>
<end>66</end>
</extent>
</part>
</mods>
</modsCollection>
%0 Conference Proceedings
%T RoBERTa-based Traditional Chinese Medicine Named Entity Recognition Model
%A Su, Ming-Hsiang
%A Lee, Chin-Wei
%A Hsu, Chi-Lun
%A Su, Ruei-Cyuan
%S Proceedings of the 34th Conference on Computational Linguistics and Speech Processing (ROCLING 2022)
%D 2022
%8 November
%I The Association for Computational Linguistics and Chinese Language Processing (ACLCLP)
%C Taipei, Taiwan
%G Chinese
%F su-etal-2022-roberta
%X In this study, a named entity recognition was constructed and applied to the identification of Chinese medicine names and disease names. The results can be further used in a human-machine dialogue system to provide people with correct Chinese medicine medication reminders. First, this study uses web crawlers to sort out web resources into a Chinese medicine named entity corpus, collecting 1097 articles, 1412 disease names and 38714 Chinese medicine names. Then, we annotated each article using TCM name and BIO tagging method. Finally, this study trains and evaluates BERT, ALBERT, RoBERTa, GPT2 with BiLSTM and CRF. The experimental results show that RoBERTa’s NER system combining BiLSTM and CRF achieves the best system performance, with a precision rate of 0.96, a recall rate of 0.96, and an F1-score of 0.96.
%U https://aclanthology.org/2022.rocling-1.8
%P 61-66
Markdown (Informal)
[RoBERTa-based Traditional Chinese Medicine Named Entity Recognition Model](https://aclanthology.org/2022.rocling-1.8) (Su et al., ROCLING 2022)
ACL